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Abstract
Recent studies on brain imaging analysis witnessed the core roles of machine learning techniques 
in computer-assisted intervention for brain disease diagnosis. Of various machine-learning 
techniques, sparse regression models have proved their effectiveness in handling high-dimensional 
data but with a small number of training samples, especially in medical problems. In the 
meantime, deep learning methods have been making great successes by outperforming the state-
of-the-art performances in various applications. In this paper, we propose a novel framework that 
combines the two conceptually different methods of sparse regression and deep learning for 
Alzheimer’s disease/mild cognitive impairment diagnosis and prognosis. Specifically, we first 
train multiple sparse regression models, each of which is trained with different values of a 
regularization control parameter. Thus, our multiple sparse regression models potentially select 
different feature subsets from the original feature set; thereby they have different powers to predict 
the response values, i.e., clinical label and clinical scores in our work. By regarding the response 
values from our sparse regression models as target-level representations, we then build a deep 
convolutional neural network for clinical decision making, which thus we call ‘ Deep Ensemble 
Sparse Regression Network.’ To our best knowledge, this is the first work that combines sparse 
regression models with deep neural network. In our experiments with the ADNI cohort, we 
validated the effectiveness of the proposed method by achieving the highest diagnostic accuracies 
in three classification tasks. We also rigorously analyzed our results and compared with the 
previous studies on the ADNI cohort in the literature.
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1. Introduction
With the advent and advance of brain imaging techniques such as Magnetic Resonance 
Imaging (MRI), Positron Emission Tomography (PET), Diffusion Tensor Imaging (DTI), 
functional MRI (fMRI), imaging-based brain disorder diagnosis or prognosis has always 
been of great interest in computer-assisted interventions (Davatzikos et al., 2008; Fan et al., 
2008; Cuingnet et al., 2011). However, it was limited to analyze the high dimensional 
neuroimaging data until the application of machine learning techniques, which are now 
playing core roles in the field (Davatzikos et al., 2008).
Given a brain image, to identify whether a subject has a certain brain disorder can be 
regarded as a classification task. From a machine learning standpoint, the prevalent 
framework for brain imaging data analysis for diagnosis can be summarized as 
preprocessing, feature extraction/selection, and classifier learning. Although machine 
learning techniques can be basically involved in all of these steps, in this paper, we mainly 
focus on the steps of feature extraction/selection and classifier learning. For applications of 
machine learning in brain imaging analysis, e.g., tissue segmentation, registration, atlas 
construction, etc., please refer to Powell et al. (2008), Liao et al. (2012) and Wang and 
Summers (2014).
One of the main challenges in brain imaging analysis is the high dimensionality of data, but 
a small number of samples are available. While various methods have been proposed for 
dimensionality reduction in the field of machine learning, due to interpretational 
requirement, it is limited for the applicable methods. Further, motivated by the principle of 
parsimony in many areas of science, i.e., the simplest explanation of a given observation 
should be preferred over more complicated ones, sparsity-inducing penalization is 
considered as one of the key techniques in machine learning. In light of these, sparse 
regression methods with different forms of regularization terms (Tibshirani, 1996; Zou and 
Hastie, 2005; Yuan and Lin, 2006), and their variants (Liu et al., 2009; Wang et al., 2011; 
Zhang and Shen, 2012; Zhou et al., 2012; Zhu et al., 2014; Suk et al., 2015b) have been 
proposed and demonstrated their validity for feature selection in medical problems.
Meanwhile, deep representation learning has recently been showing state-of-the-art 
performances in various fields of computer vision, speech recognition, natural language 
processing, and medical image analysis. To this end, it has also been considered as one of 
the major tools in brain imaging data analysis (Li et al., 2014b; Plis et al., 2014; Suk et al., 
2015a; 2016b; Pereira et al., 2016; Brosch et al., 2016; Dou et al., 2016) by achieving 
promising performances. In deep learning, a Convolutional Neural Network (CNN) is of 
main stream for image analysis thanks to its modeling characteristic that helps discover local 
structural or configural relations in observations. While it is desirable to apply CNNs to 
learn feature representations from a whole-brain MRI for brain disease diagnosis, it is still 
limited because of its huge number of network parameters, e.g., millions number of 
parameters, that should be learned from a small number data, e.g., less than 1000 samples. In 
this regard, Brosch and Tam (2013) downsampled images before training a convolutional 
restricted Boltzmann machine for manifold learning of brain MRIs. However, image 
downsampling inevitably causes information loss of subtle structural changes especially in 
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Mild Cognitive Impairment (MCI). Unlike the conventional methods that were mostly used 
for feature representation learning, in this work, we utilize a CNN for ensemble modeling by 
finding a non-linear mapping function from matrix-formed predictions, whose dimension is 
considerably lower than the original dimension of imaging features, to make a clinical 
decision.
One prevalent step of the sparsity-inducing regularization methods is to choose the optimal 
value of a regularization control parameter, mostly via cross-validation with a grid search 
strategy. It is, however, possible that for different validation sets, it can be different for the 
optimal value of a regularization control parameter. In this work, instead of choosing a 
single value for the regularization control parameter, we propose to build a set of sparse 
regression models, each of which is trained with different values of the regularization control 
parameter. We regard outputs of the sparse regression models, e.g., clinical label and clinical 
scores in our work, as target-level representations. This is comparable to the previous work 
that mostly used the sparse regression method for feature selection and then trained a 
classifier such as support vector machine based on the selected features only. In our work, 
the sparse regression model plays the role of predicting target outputs, which we consider as 
abstract feature representation, along with informative features selection. It is noteworthy 
that the predicted values from multiple sparse regression models are stacked in an ascending 
or descending 1 order based on the regularization control parameter values. In this way, we 
can exploit the prediction values of “neighboring” sparse regression models, which are 
trained with relatively similar regularization control parameter values, as additional 
information. We then build a CNN that hierarchically combines the prediction values from 
sparse regression models, i.e., target-level representations, for MRI-based brain disease 
diagnosis, especially, Alzheimer’s Disease (AD) and its prodromal stage, MCI.
Our deep network discovers the optimal weights to ensemble multiple sparse regression 
models in a hierarchical and non-linear way, which thus we call ‘Deep Ensemble Sparse 
Regression Network’ (DeepESRNet). The proposed method can be understood as ensemble 
of expert systems. That is, sparse regression models with different regularization control 
values can be considered as experts that output their own prediction values. The prediction 
values of different experts are then combined by CNN that finds non-linear weighting 
coefficients among them.
To our knowledge, one of the beauties of CNN is to hierarchically integrate information 
distributed in the input by means of convolution and pooling operations. We utilize this 
feature to integrate the outputs from multiple sparse regression models, thus to build a strong 
classifier. In a convolution layer, the learnable kernels find relations among outputs, i.e., 
predicted clinical label and clinical scores, from different sparse regression models. In a 
pooling layer, the max operation plays the role of drawing a mid-level decision among 
neighboring regression models. By repeating these operations over layers, our CNN finally 
make a decision by integrating all the information from multiple sparse regression models.
1In our work, we stack in an ascending order. However, there is no difference in the framework.
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The rationale of using a CNN is two aspects: (1) In machine learning, it is generally known 
that combining multiple classifiers is helpful for the improvement of the performance of 
individual classifiers (Kittler et al., 1998). In this work, we use a CNN with a target-level 
representation as input to combine the outputs of multiple sparse regression models. Due to 
the use of non-linear activation functions, our CNN finds non-linear weight coefficients in 
combining the outputs from multiple sparse regression models. (2) In our target-level 
representation, element values (i.e., predicted clinical label and clinical scores) in the same 
row are obtained from the same sparse regression model, thus they are naturally related to 
each other. In the meantime, element values of neighboring rows are from different sparse 
regression models trained with different values of the regularization control parameter. Note 
that our target-level representation is obtained by stacking the outputs of multiple sparse 
regression models in an ordered way based on their regularization control parameter values. 
Sparse regression models trained with slightly different regularization control parameter 
values are likely to produce similar outputs. Thus, it is expected that values of the 
neighboring rows are more related to each other than those of the rows apart in the target-
level representation. A CNN is suitable to well discover such local configural features and to 
combine the overall information hierarchically.
The main contributions of our work can be two-fold: 1) The different values of the 
regularization control parameter are used to select different feature subsets with different 
weight coefficients. Hence, different regression models can predict both clinical status and 
clinical scores in different feature spaces. Also, the use of target-level representations from 
multiple sparse regression models has the effect of reducing dimensionality of an 
observation, allowing us to use CNN with less concern of data insufficiency. 2) Our 
DeepESRNet built on the outputs of the sparse regression models finds a (sub)optimal way 
of combining the regression models in a non-linear manner with the following rationales. 
First, the target-level representation values (i.e., response values of clinical label and clinical 
scores in our work) of a sparse regression model are highly related to each other (intra-
model relation). Second, sparse regression models trained with similar regularization control 
parameter values tend to find similar weight coefficients, thus similar target-representations 
(inter-model relation). In these regards, we couple the target-level representation of the same 
sparse response model(s) and of the neighboring sparse response models via local learnable 
kernels. The local combination allows us to exploit complementary information and their 
hierarchical and non-linear integration over the whole target-level representation helps make 
a robust clinical decision. It is also noteworthy that since we treat the outputs from 
individual sparse regression models as target-level representation, we justify to re-use the 
training data for learning network parameters after training sparse regression models.
Methodologically, our method can be considered as a cascading classifier, which is one case 
of ensemble learning. Our sparse regression models take a vector of features and output 
clinical label and clinical scores, which are usually used for making a decision. As a 
cascading classifier, our method further uses such outputs as inputs to another model, i.e., 
CNN.
The rest of the paper is organized as follows: In Section 2, we review the previous work on 
brain imaging-based AD disease diagnosis in the literature. We then describe the dataset 
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used in this work and explain the steps involved in preprocessing for feature extraction in 
Section 3. We elaborate upon the basics in sparse linear/logistic regression and propose a 
novel deep ensemble sparse regression network in Section 4. The experimental results on the 
public ADNI dataset are presented by comparing with competing methods in Section 5 and 
the discussion on our experimental results and comparison with state-of-the-art results in the 
literature are detailed in Section 6. We conclude this paper by summarizing the proposed 
method and suggesting future research directions in Section 7.
2. Related work
The small number of training samples compared to high-dimension of imaging data has been 
one of the main challenges in brain imaging-based disease diagnosis. To circumvent the 
problem, various machine learning techniques were proposed in the literature. Depending on 
their strategies, techniques can be categorized into 1) feature embedding (Roweis and Saul, 
2000; He et al., 2006; Liu et al., 2013) and 2) feature selection (Wang et al., 2011; Zhu et al., 
2014; Tohka et al., 2016). Basically, the common goal of the methods of both categories is to 
learn dimension-reduced features or representations from a small number of training 
samples, while still pertaining useful information for target tasks. Specifically, the feature 
embedding methods find a latent low-dimensional space, where the original features can be 
efficiently represented without losing much information. Meanwhile, the feature selection 
methods try to find associations among features, based on which they select features 
informative to identify the incidence of a brain disease. From a clinical perspective, the 
interpretability of the features involved in diagnosis is of great importance. In this regard, the 
feature selection methods are generally preferred to the feature embedding methods, and 
thus we consider the feature selection methods in this paper.
Among various feature selection methods, sparse regression models have shown good 
promises in the small sample size problem with different forms of regularization. The Least 
Absolute Shrinkage and Selection Operator (LASSO) regression model (Tibshirani, 1996) 
uses an ℓ1-norm to induce sparsity in the regression coefficients for each target response 
variable independently. To circumvent the limitation of LASSO, i.e., independence in 
sparsity of coefficients, Zou and Hastie (2005) proposed the elastic net penalty which is 
capable of retaining the sparse property of LASSO and utilizing correlation among 
predictors simultaneously. Yuan and Lin (2006) proposed the group LASSO penalty that 
leads a group sparse property by imposing penalties in a group-wise manner via an ℓ2, 1-
norm, and thus select features whose weights are non-zero to all predictors within the 
selected groups. This group LASSO has been successfully applied in brain imaging-based 
AD/MCI diagnosis (Wang et al., 2011; Zhang and Shen, 2012; Wee et al., 2012; Suk et al., 
2015b). For example, Zhang and Shen (2012) designed a multi-task sparse regression model 
with an ℓ2, 1-norm for AD diagnosis. Wang et al. (2011) proposed sparse joint classification 
and regression with logistic regression function for classification and linear regression 
function for regression. Zhou et al., introduced a smoothness constraint along with ℓ1- and 
ℓ2, 1-norm penalties for predicting disease progression. Suk et al. (2015b) devised a 
discriminative group sparse representation method by penalizing a large within-class 
variance and a small between-class variance in estimating functional connectivities.
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In the meantime, inspired by great successes in the fields of computer vision and speech 
recognition, deep learning methods have been applied to discover hierarchical features in 
brain images, too. For example, Suk et al. (2015a) used a stacked auto-encoder to find non-
linear relations among gray matter volumes of brain regions. Suk et al. (2014) also proposed 
a generative deep learning to integrate structural and functional patterns inherent in MRI and 
PET, respectively, by learning shared representations. Similarly, Ithapu et al. (2015) also 
devised a deep learning algorithm called a randomized denoising auto-encoder marker to 
integrate multimodal data of PET and MRI. However, due to complex composition of non-
linear patterns in deep learning, it still remains challenging to interpret the learned 
representations. Hence, unlike other fields such as computer vision and speech recognition, 
it is still popular to use hand-crafted features for neuroscientific interpretations in the field of 
brain disease diagnosis. In this paper, we propose a novel brain disease diagnosis system 
based on sparse regression models with interpretable volumetric features, and further use a 
deep learning method to combine the regression models to make a clinical decision.
3. Materials and image processing
3.1. Dataset
We analyzed a baseline MRI dataset from the ADNI database (http://www.loni.ucla.edu/
ADNI). The dataset included 805 subjects of 186 (AD), 393 (MCI), and 226 (Normal 
Control, NC). For the MCI subjects, they were clinically further subdivided into 167 
progressive MCI (pMCI), who progressed to AD in 18 months, and 226 stable MCI (sMCI), 
who did not progress to AD in 18 months. Each subject had both Mini-Mental State 
Examination (MMSE) and Alzheimer’s Disease Assessment Scale - Cognition (ADAS-Cog) 
scores recorded. The subjects were in the age between 55 and 90, with a study partner, who 
provided an independent evaluation of functioning. All of 805 subjects met the following 
general inclusion criteria: (a) NC subjects: an MMSE between 25 and 30 (inclusive), a 
clinical dementia rating (CDR) of 0, non-depressed, non-MCI, and non-demented; (b) mild 
AD subjects: an MMSE score between 18 and 27 (inclusive), a CDR of 0.5 or 1.0, and met 
the National Institute of Neurological and Communicative Disorders and Stroke and the 
Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) criteria for 
probable AD. Demographic and clinical information of subjects is provided in Table 1.
3.2. Preprocessing
All structural MRI data in this study were acquired using 1.5T scanners. The baseline MRI 
data were downloaded from ADNI in the Neuroimaging Informatics Technology Initiative 
(NIfTI) format, which had already been processed for spatial distortion correction caused by 
gradient nonlinearity and B1 field inhomogeneity. We further processed the MR images by 
applying the typical procedures of Anterior Commissure (AC)-Posterior Commissure (PC) 
correction, skull-stripping, and cerebellum removal. Specifically, we used MIPAV software 2 
for AC-PC correction, resampled images to 256 × 256 × 256, and applied N3 algorithm 
(Sled et al., 1998) to correct intensity inhomogeneity. An accurate and robust skull stripping 
(Wang et al., 2014) was performed along with cerebellum removal. To ensure the clean and 
2Available at ‘ http://mipav.cit.nih.gov/clickwrap.php’
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dura removal, we manually reviewed the skull-stripped images. Then, FAST in FSL package 
3
 was used for structural MRI image segmentation into three tissue types of Gray Matter 
(GM), White Matter (WM), and CerebroSpinal Fluid (CSF). 4 We finally parcellated them 
into 93 Regions Of Interest (ROIs), whose list is provided in Table B1, by warping the atlas 
of Kabani et al. (1998), which has been widely used for AD/MCI diagnosis studies 
(Davatzikos et al., 2011; Negash et al., 2013; Suk et al., 2015a) to each subject’s space via 
HAMMER (Shen and Davatzikos, 2002), although many other advanced registration 
methods could be also used (Avants and Gee, 2004; Zacharaki et al., 2009; Xue et al., 2006; 
Shen et al., 1999). Next, we generated the regional volumetric maps, called RAVENS maps, 
using a tissue preserving image warping method (Davatzikos et al., 2001). In this work, we 
considered only the spatially normalized GM densities, due to its relatively high relevance to 
AD compared to WM and CSF (Liu et al., 2012). For each of the 93 ROIs, we computed the 
GM tissue volumes, which is widely used in the field for AD/MCI diagnosis (Davatzikos et 
al., 2011; Hinrichs et al., 2011; Zhang and Shen, 2012; Suk et al., 2015a), as features, i.e., 
93-dimensional features from an MR image. 5
4. Deep ensemble sparse regression network
4.1. Notations
Throughout this paper, we denote matrices as boldface uppercase letters, vectors as boldface 
lowercase letters, and scalars as normal italic letters, respectively. For a matrix X = [xi j], its 
i-th row and j-th column are denoted as xi and xj, respectively. Also, we denote the 
Frobenius norm and ℓ2, 1-norm of a matrix X as  and 
, respectively. We use a superscript ⊤ for transpose of a 
vector or a matrix.
4.2. Sparse linear/logistic regression
Assume that we are given N samples of a training set  = {X, T}, where X ∈ ℝ D ×N and T 
∈ ℝ L ×N denote, respectively, D-dimensional brain imaging features and the corresponding 
L-dimensional target values. Sparse regression models are formulated in the form of an 
optimization problem as follows:
(1)
3Available at ‘ http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/’
4Note that when normalization is conducted with the whole-brain images, it can introduce unexpected structural differences for 
tissues. That is, there is no any difference but it can be caused for the difference by normalization due to the effect of the neighboring 
tissue that does show structural difference. One common way of minimizing such unexpected error is to normalize with the tissue-
segmented images, instead of the whole-brain images (Mechelli et al., 2005).
5In this paper, we exploit regional gray matter tissue volumes based on the fact that brain atrophy is one of the main neuropathological 
changes with AD. However, visual features with Scale-Invariant Feature Transform (SIFT) (Lowe, 1999) or Histogram of Oriented 
Gradients (HOG) (Dalal and Triggs, 2005) can also be good alternatives to the ROI-based regional features.
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where ℒ ( ; Θ) denotes a loss function and Ω(Θ) denotes a regularization term over a 
parameter set Θ, and λ is a regularization control parameter.
In terms of brain disease diagnosis, xi can include brain imaging features, e.g., GM tissue 
volumes of 93 ROIs xi ∈ ℝ93 in our work, and T can be defined with clinical outputs, e.g., 
clinical label6 and two clinical scores of MMSE and ADAS-Cog ti ∈ ℝ4 in our work. 
Earlier, Zhang and Shen (2012) and Wang et al. (2011) independently designed a sparse 
multi-task learning model with the rationale that since the prediction of clinical label and 
clinical scores are inter-related it is reasonable to learn the models jointly rather than each 
prediction task, separately. The main difference between these two methods lies in the way 
of defining a loss function ℒ. Specifically, Zhang and Shen used a single least square error 
function for both clinical label prediction (classification task) and clinical scores prediction 
(regression task) as follows
(2)
where Θ = W ∈ ℝ D ×L. In the meantime, Wang et al. used different error functions for 
classification and regression tasks, namely, a cross-entropy function for classification and a 
least square error function for regression as follows
(3)
(4)
(5)
where C denotes the number of classes, Θce = Z ∈ ℝ D ×C, ti j = 1 iff xi belongs to the class 
j, T̃ = [t1; …; tR], R (= L − C) denotes the number of clinical scores, and Θls = P ∈ ℝ D ×R.
However, these loss functions themselves do not enforce sparsity. The regularization term 
Ω(Θ) plays the role of selecting informative features for target tasks and different forms of 
the regularization term produce different sets of selected features. Among different forms of 
regularization in the literature, in this paper, we consider an ℓ2, 1-norm regularizer that 
induces sparsity in a group-wise manner by following Wang et al. (2011) and Zhang and 
6We use a class indicator vector ti ∈ {0, 1}2 with a zero-one encoding, i.e., ti j = 1 iff xi belongs to the class j; otherwise ti j = 0.
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Shen (2012). Let Θ denote a weight coefficient matrix, i.e., Θ = W for Eq. (2) and Θ = [Z P] 
for Eq. (3). Note that each element in a column θj of Θ assigns a weight to each of the 
observed features in predicting the j-th response t̂i j for xi. The regularizer of Ω(Θ) = ||Θ||2, 1 
penalizes all coefficients in the same row of Θ and thus guides to select features that are 
informative to predict all the response variables jointly (Liu et al., 2009).
After finding the optimal weight coefficients Θ̂ with respect to a certain value of the control 
parameter λ in Eq. (1), we can then predict the response values for an input vector x* as 
follows:
(6)
We consider the predicted vector t̂ as target-level representations obtained from a sparse 
regression model and utilize it as input to our CNN as described below for clinical decision 
making.
4.3. Deep ensemble sparse regression network
Unlike the conventional approach that finds the optimal control parameter λ in Eq. (1) via 
cross-validation from a predefined parameter space, in this work, we build multiple sparse 
regression models, as many as the size M of the predefined parameter space Λ. 7 It is 
noteworthy that we use the predicted vector obtained by Eq. (6) as a target-level 
representation of the original input vector. Specifically, we exploit the M learned sparse 
regression models with different values of the control parameter λ as ‘target-level 
representation learners’ that transform an input vector xi into a matrix form 
, where  denotes the predicted 
vector by a regression model trained with λ equal to the m-th value in the parameter set Λ. 
Fig. 1 illustrates the construction of a target-level representation matrix from M sparse 
regression models, each of which was trained with different value of a regularization control 
parameter. The target-level representation matrix is then fed into our CNN for clinical 
decision making as described below.
Note that different values of a regularization control parameter λ cause to select different 
feature subsets in learning sparse regression models. Therefore, our M sparse regression 
models produce different target-level representations, estimated from possibly different 
feature subsets. However, it is likely that sparse regression models trained with similar 
regularization control parameter values tend to have similar weight coefficients and thus, to 
select similar feature subsets. There can be high relations among neighboring rows of a 
7In our implementation, we used a SLEP toolbox for sparse model learning, which requires a regularization control parameter, i.e., λ, 
to be in the range of [0, 1], and rescales the value internally. Based on our earlier work (Suk et al., 2015b; 2016a), where we observed 
that parameter values of higher than 0.3 were not useful and never chosen in cross-validation, we thus defined the parameter space 
with 10 values equally spaced between 0.01 and 0.3. As for the size of parameter space (M = 10), it is determined empirically.
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target-level representation in Fig. 1. In the meantime, since the target-level representations 
are basically related to clinical status and clinical scores jointly estimated from the original 
brain imaging features, the values are highly related to each other. Thus, there can be high 
relations among elements of the same row in a target-level representation. In these regards, 
we couple elements of the same row (intra-model relation) and elements of neighboring 
rows (inter-model relation) in a target-level representation Ti together via learnable kernels 
that find configural relations locally. For hierarchical integration of the input representation 
Ti, we employ a CNN that can discover configural relations inherent in inputs. It should be 
emphasized that to our best knowledge, this is the first work that systematically combines 
multiple regression models via CNN for classification.
Fig. 2 illustrates our CNN that takes target-level representations obtained from multiple 
sparse regression models as input and discovers non-linear relations among them in a 
hierarchical manner for brain disease diagnosis. From a pattern classification standpoint, our 
CNN is an ensemble classifier that systematically finds the relations of different sparse 
regression models. Thus, we call our network as ‘Deep Ensemble Sparse Regression 
Network’ (DeepESRNet).
In our DeepESRNet, we have three types of layers, namely, convolution layer, pooling layer, 
and fully connected layer. At a convolution layer, the previous layer’s outputs (called feature 
maps) are convolved with learnable kernels and go through a non-linear activation function 8 
to form the feature maps of the current layer as follows:
(7)
where * is a convolution operator, a superscript (ℓ) denotes a layer index,  and F (l − 1) 
are, respectively, the j-th feature map and the index set of feature maps in the layer (l − 1), 
 is a trainable kernel between the i-th feature map in the layer (l − 1) and j-th feature map 
in the layer l,  is a bias term for a feature map j, and f (·) is a non-linear activation 
function. A pooling layer is interspersed with the convolution layer for reducing the 
resolution of feature maps. In our DeepESRNet, we assign a max-pooling layer that 
partitions an input feature map into a set of non-overlapping regions and outputs the 
maximum value for each region. Lastly, the fully connected layer is the same as the 
conventional multilayer neural network such that the inter-layer units are fully connected but 
with no units within the same layer connected. With this fully connected layer, we finally 
integrate all the information from the outputs from multiple sparse regression models, i.e., 
predicted clinical status and clinical scores, for making a clinical decision at the top output 
layer of our DeepESRNet.
8As for the activation function, while the logistic sigmoid function or hyperbolic tangent function has been commonly used, thanks to 
its great success in recent applications, we used a Rectified Linear Unit (ReLU) (Nair and Hinton, 2010), defined as f (a) = max (0, a).
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Fig. 2 shows an example of applying our DeepESRNet to target-level representations 
obtained from 10 sparse regression models. Given a target-level representation 
, the first convolution layer with 10 feature maps couples target-level 
representation values in the same row and target-level representation values of neighboring 
rows in  via a kernel  in size according to Eq. (7), resulting in 
. A second convolution layer with 30 feature maps follows to find 
associations among the values within the same feature maps and also across different feature 
maps simultaneously via a kernel  followed by a non-linear transformation, 
producing . We then apply a max-pooling operation to each feature map in 
the second layer, which downsamples the features maps into  with a non-
overlapping sliding window of 2 × 1 in size. Beyond the max-pooling layer, the network 
corresponds to a conventional multi-layer neural network with two hidden layers (100 units 
and 50 units, respectively) and one output layer by taking vectorized values of the 30 feature 
maps in the max-pooling layer as input. For the output layer, we use a softmax function for 
classification.
In our DeepESRNet, we have network parameters, i.e., kernels  and biases  in 
convolutional layers and also connection weights and biases in the top three multi-layer 
neural network, that should be learned from data. To train our DeepESRNet, we use a 
backpropagation algorithm (Rumelhart et al., 1986) with a mini-batch gradient descent 
method (Cotter et al., 2011).
5. Experimental results
In this section, we validate the effectiveness of the proposed method for AD/MCI diagnosis 
or prognosis with MRI by comparing with competing methods. We consider three binary 
classification problems: AD vs. NC, MCI vs. NC, pMCI vs. sMCI. In MCI vs. NC 
classification, the samples of both pMCI and sMCI subjects were used for MCI class. Due to 
the limited number of samples, we applied a 10-fold cross validation technique. Specifically, 
we randomly partitioned the dataset into 10 subsets, each of which included 10% of the 
samples per class. We repeated experiments for each classification problem 10 times, by 
using 9 out of 10 subsets for training and the remaining one for testing at each time.
5.1. Experimental settings
With regard to the structure of deep neural networks, i.e., the number of layers and the 
number of feature maps in each layer, there is no golden rule for those. In this work, we 
empirically designed our DeepESRNet with two convolutional layers followed by one max-
pooling layer, two fully connected layers, and one output layer as shown in Fig. 2. The 
kernels for two convolution layers were 3 × 4 and 3 × 1 in size, respectively, with a stride of 
1. In the max-pooling layer, a kernel of 2 × 1 in size was used with a stride of 2. For two 
fully connected layers, we set 100 hidden units and 50 hidden units sequentially. We also 
applied a batch normalization (Ioffe and Szegedy, 2015) to convolution and fully-connected 
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layers except for the last output layer for fast training. No dropout (Srivastava et al., 2014) 
was involved based on the work of Ioffe and Szegedy (2015), where they empirically 
presented that dropout could be removed in a batch-normalized network. The network 
parameters were trained with a stochastic gradient descent approach (Li et al., 2014a) with a 
mini-batch size of 50, a learning rate of 0.001, a weight decay of 0.005, and a momentum 
factor of 0.9. We used a MatConvNet toolbox 9 (Vedaldi and Lenc, 2015) to train our 
DeepESRNet. In regard to computational time, for training our DeepESRNet, it took less 
than 1 minute in a computer with 3.4 GHz Intel(R) Core i7 CPU and 16GB 1333 MHz 
DDR3 RAM. All computations were conducted with CPU only without involving GPU 
computation. The short training time of our CNN was resulted from the greatly reduced 
input size after applying sparse regression models.
We considered two sparse regression models, namely, 1) Multi-Output Linear Regression 
with ℓ2, 1-norm regularization (MOLR) (Yuan and Lin, 2006; Zhang and Shen, 2012) and 2) 
Joint Linear and Logistic Regression with ℓ2, 1-norm regularization (JLLR) (Wang et al., 
2011) with the loss function defined by Eqs. (2) and (3), respectively. We set the space of the 
sparsity control parameter λ with M = 10 values equally spaced between 0.01 and 0.3. 10 By 
taking the outputs of 10 regression models for each of MOLR and JLLR, we trained MOLR
+DeepESRNet and JLLR+DeepESRNet, separately.
To validate the effectiveness of the proposed method, we compared our method with the two 
baseline sparse regression models and their variants of the following methods
• MOLR+SVM: This method first finds the optimal weight coefficients Ŵ in Eq. 
(2) and then selects the informative features based on the learned weight 
coefficients. Specifically, after optimizing Eq. (2), we had some zero row vectors 
in Ŵ and discarded the corresponding features. With the selected features only, 
we then trained a linear Support Vector Machine (SVM) for classification.
• JLLR+SVM: This method jointly finds the optimal weight coefficients P̂ and Ẑ 
in Eq. (3) and then allows to select the informative features based on the learned 
weight coefficients. Specifically, after optimizing Eq. (3), we had some zero row 
vectors in [Ẑ P̂] and discarded the corresponding features. With the selected 
features only, we then trained a linear SVM for classification.
For a linear SVM in the competing methods of MOLR+SVM and JLLR+SVM, we 
determined the model parameter C via 5-fold nested cross-validation with the space of C 
defined as {10−5, 10−4, …, 105} and trained by using the LIBSVM toolbox.11
5.2. Performance evaluation and comparison
Let TP, TN, FP, and FN denote, respectively, True Positive, True Negative, False Positive, 
and False Negative. For quantitative evaluation and comparison among the competing 
methods, we considered the metrics of accuracy = (TP + TN)/(TP + TN + FP + FN), 
9Available at ‘ http://www.vlfeat.org/matconvnet/’
10For sparse model training, we used a SLEP toolbox available at’ http://www.public.asu.edu/~jye02/Software/SLEP/index.htm,’ 
where the control parameter is required to be set between 0 and 1 because its value is internally rescaled (Liu et al., 2010).
11Available at ‘ http://www.csie.ntu.edu.tw/~cjlin/libsvm/’.
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sensitivity = TP/(TP + FN), specificity = TN/(TN + FP), Balanced Accuracy (BA) = 
(sensitivity+specificity)/2, Positive Predictive Value (PPV) = TP/(TP + FP), and Negative 
Predictive Value (NPV) = TN/(TN + FN). We also considered Area Under the receiver 
operating characteristics Curve (AUC), which is widely used to evaluate the performance of 
diagnostic tests in brain disease diagnosis as well as other medical areas.
5.2.1. MOLR as a baseline regression model—The performance comparison among 
the competing methods with MOLR involved in different ways is presented in Table 2. The 
proposed method of MOLR+DeepESRNet achieved mean classification accuracies of 
90.28% (AD vs. NC), 74.20% (MCI vs. NC) and 73.28% (pMCI vs. sMCI). Our MORL
+DeepESRNet improved the mean accuracies by 5.35% (AD vs. NC), 9.54% (MCI vs. NC), 
and 9.93% (pMCI vs. sMCI) in comparison with MOLR and by 3.41% (AD vs. NC), 7.58% 
(MCI vs. NC), and 6.62% (pMCI vs. sMCI) in comparison with MOLR+SVM.
For the metrics of sensitivity and specificity, our MOLR+DeepESRNet also outperformed 
the competing methods for the classification tasks of AD vs. NC and pMCI vs. sMCI. It is 
remarkable that our method enhanced the sensitivity by 14.51% (vs. MOLR) and 8.55% (vs. 
MOLR+SVM) for the most challenging task of pMCI vs. sMCI. For MCI vs. NC 
classification, MOLR achieved the highest sensitivity of 79.40%. However, in terms of the 
balanced accuracy that avoids inflated performance estimates on imbalanced dataset, e.g., 
MCI vs. NC classification in our case, compared to the competing methods (MOLR/MOLR
+SVM), our MOLR+DeepESRNet improved by 5.39%/3.47% (AD vs. NC), 6.99%/8.49% 
(MCI vs. NC), and 9.18%/6.91% (pMCI vs. sMCI).
Regarding PPV and NPV, our MOLR+DeepESRNet achieved the highest PPVs of 85.50% 
in AD vs. NC and 81.92% in MCI vs. NC, and the highest NPVs of 94.25% in AD vs. NC 
and 80.12% in pMCI vs. sMCI. In the meantime, MOLR showed the highest PPV of 64.63% 
in pMCI vs. sMCI and the highest NPV of 73.08% in MCI vs. NC.
It is noteworthy that in terms of the AUC, which can be thought as a measure of the overall 
performance of a diagnostic test, the MOLR+DeepESRNet showed the best AUCs of 0.9260 
in AD vs. NC, 0.7662 in MCI vs. NC, and 0.7192 in pMCI vs. sMCI. Compared to MOLR/
MOLR+SVM, our method increased the AUCs by 0.0095/0.0030 (AD vs. NC), 
0.0420/0.0472 (MCI vs. NC), and 0.0368/0.0068 (pMCI vs. sMCI).
5.2.2. JLLR as a baseline regression model—Table 3 shows the performance of our 
JLLR+DeepESRNet as well as the performance of the competing methods. Our JLLR
+DeepESRNet achieved the mean accuracies of 91.02% (AD vs. NC), 73.02% (MCI vs. 
NC), and 74.82% (pMCI vs. sMCI). Compared to the competing methods, i.e., JLLR/JLLR
+SVM, our method improved the mean accuracies by 6.33%/4.63% (AD vs. NC), 4.47%/
6.24% (MCI vs. NC), and 7.14%/8.43% (pMCI vs. sMCI).
In regard to the fact that the higher the sensitivity, the lower the chance of mis-diagnosing 
patients, which is of great importance in the clinic, it is promising that our JLLR
+DeepESRNet overwhelmed the competing methods in sensitivity. Specifically, our method 
improved the sensitivity, compared to JLLR/JLLR+SVM, by 7.77%/5.1% (AD vs. NC), 
Suk et al. Page 13
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
4.36%/4.73% (MCI vs. NC), and 6.8%/8.99% (pMCI vs. sMCI). It was also observed for 
high improvements in specificity across the three classification tasks, i.e., 4.99%/3.76% (AD 
vs. NC), 8.8%/12.53% (MCI vs. NC), and 8.58%/9.43% (pMCI vs. sMCI) in comparison 
with JLLR/JLLR+SVM.
In PPV and NPV, our JLLR+DeepESRNet showed the highest PPVs of 87.08% (AD vs. 
NC), 82.96% (MCI vs. NC), and 71.43% (pMCI vs. sMCI) and the highest NPVs of 94.23% 
(AD vs. NC), 55.77% (MCI vs. NC), and 77.47% (pMCI vs. sMCI). It is remarkable that in 
the task of pMCI vs. sMCI, the improvements for PPV by our JLLR+DeepESRNet were 
15.77% (vs. JLLR) and 16.36% (vs. JLLR+SVM).
Regarding the AUC metric, our JLLR+DeepESRNet showed the best AUCs of 0.9272 in AD 
vs. NC, 0.7361 in MCI vs. NC, and 0.7539 in pMCI vs. sMCI. Compared to JLLR+SVM, 
our method increased the AUCs by 0.0052 (AD vs. NC), 0.0155 (MCI vs. NC), and 0.0415 
(pMCI vs. sMCI).
6. Discussion
6.1. Visual inspection of target-level representation
To validate our rationale of using CNN, which is designed to extract local relationship in our 
target-level representation and to hierarchically integrate information, we first computed 
correlation coefficients among rows or columns of the target-level representations. Fig. 3 
presents samples of the target-level representations and the correlation matrix estimated 
from our dataset, for which a sliding window of 4 × 4 in size, i.e., 4 consecutive sparse 
regression models, was considered with a stride of 1. Specifically, for the number Q of 
target-level representations of 10 × 4 in size, we shaped them into a 3-dimensional tensor of 
4 × 4 × (7 × Q), where 7 comes from the use of a sliding window of 4 × 4 in size. The large 
tensor was then used to compute the 4 × 4 correlation matrix. Clearly, there exists the 
correlations among target-level representations predicted from sparse regression models with 
similar control parameter values.
6.2. Performance comparison
To better justify the effectiveness of the proposed method, we further conducted statistical 
significance testing. The null hypothesis was that the combination of sparse regression 
models with the proposed DeepESRNet, i.e., MOLR+DeepESRNet and JLLR
+DeepESRNet, produces the same mean accuracies with the competing methods, i.e., 
MOLR, MOLR+SVM, JLLR, and JLLR+SVM. We used the Wilcoxon signed rank test 
(Wilcoxon, 1945) to assess whether the differences in classification accuracies between two 
methods are at a significant level. The resulting p-values are presented in Table 4, where it is 
noticeable that all the null hypothesis can be rejected beyond the 95 percent confidence level 
(i.e., p-value < 0.05). Hence, we can say that the proposed method outperformed the 
competing methods in terms of statistical significance by rejecting the null hypothesis 
beyond the 95 percent confidence level.
Although it is not clear why some people with MCI progress to AD and some do not, MCI is 
considered as an early stage of dementia in the particular form and it is estimated that 
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approximately 10–15% of individuals with MCI progress to AD in one year (Alzheimer’s 
Association, 2012). In this perspective, it is momentous to correctly discriminate pMCI from 
sMCI so that pMCI subjects can take benefit from a proper treatment for possible delay of 
progressing to AD. In our experiments, our MOLR+DeepESRNet and JLLR+DeepESRNet 
improved, respectively, by 6.62% (vs. MOLR+SVM) and 7.14% (vs. JLLR) compared to the 
maximal accuracies of their counterpart methods. It is also noteworthy that our JLLR
+DeepESRNet achieved the best performance across seven metrics considered in our work.
From a clinical standpoint, the PPV is also of great importance, which measures the 
proportion of correctly diagnosed subjects belonging to AD, MCI, or pMCI in the tasks of 
AD vs. NC, MCI vs. NC, and pMCI vs. sMCI, respectively. Based on a recent report by 
Alzheimer’s Association (2012), the AD prevalence is projected to be 11 million to 16 
million by 2050. For MCI and pMCI, although there is high variation among reports 
depending on definitions, the median of the prevalence estimates of MCI or pMCI in the 
literature is 26.4% (MCI) and 4.9% (amnestic MCI) (Ward et al., 2012). Regarding the AD 
prevalence by 2050, our JLLR+DeepESRNet, which maximally achieved the PPV of 
87.08% in the classification of AD and NC, can correctly identify 9.5788 million to 13.9328 
million of subjects with AD, while JLLR+SVM, whose respective PPV was 82.25%, can 
identify 9.0475 million to 13.16 million of subjects with AD. Accordingly, our method can 
correctly identify as many as 0.5313 million to 0.7728 million of subjects more than JLLR
+SVM.
We also compared our two methods, each of which involved different baseline regression 
models but with the same Deep-ESRNet architecture, and summarized results in Fig. 4. 
From the figure, there is no significant difference between them across all three tasks, i.e., 
AD vs. NC, MCI vs. NC, and pMCI vs. sMCI. In our statistical significance testing with the 
Wilcoxon signed rank test (Wilcoxon, 1945), the p-values were 0.25 (AD vs. NC), 0.4570 
(MCI vs. NC), and 0.2109 (pMCI vs. sMCI), for which we cannot reject the null hypothesis 
that their mean accuracies are the same in the different tasks.
6.3. Comparison with (deep) neural networks
It may be possible to think of mapping the ensemble of sparse regression models into a 
conventional multi-layer perceptron or a deep neural network by regarding a subset of 
hidden units being one sparse-model and other subsets of hidden units as other sparse-
models, etc. In this regard, we conducted experiments with (deep) neural networks, into 
which the 93 MR features were fed, by varying the number of hidden layers and their 
respective units. For all the networks, we initialized the parameters, i.e., connection weights 
and biases, via greedy layer-wise pretraining (Hinton and Salakhutdinov, 2006) by using a 
Stacked Auto-Encoder (SAE) (Bengio et al., 2007),12 and trained with a stochastic gradient 
descent approach (Li et al., 2014a) with a learning rate of 0.01, a weight decay of 0.0001, 
and a momentum factor of 0.9. We summarized the results in Table 5. Overall, for the 
classification of AD vs. NC, there were no significant differences in performance among the 
neural networks with different architectures considered in our experiments. However, for the 
12We also conducted experiments by pretraining the network with Deep Belief Network (DBN) (Hinton and Salakhutdinov, 2006) and 
reported the results in Appendix A.
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task of pMCI vs. sMCI, the 3-layer neural network, i.e., 
93(input)-50(hidden)-30(hidden)-2(output), showed the superiority to the other networks. 
When comparing with the performances of our method in Tables 2 and 3, the proposed 
method outperformed the (deep) neural network-based methods.
In the meantime, in order to validate the use of a CNN in our method, we also performed 
experiments with (deep) neural networks by taking the vectorized target-level 
representations as input. We considered the same network architectures in Table 5 and 
trained networks with the same parameter settings. The results are summarized in Table 6. In 
comparison of the results in Table 6 with the performances in Tables 2 and 3, the proposed 
method again outperformed (deep) neural networks that took the vectorized target-level 
representation as input.
6.4. Comparison with previous studies on ADNI dataset
We compared the maximal accuracies achieved by our JLLR+DeepESRNet with the 
accuracies of the previous studies of MRI-based AD/MCI diagnosis on the ADNI cohort in 
the literature. Note that, due to the difference in dataset size and different approaches for 
extracting features (they all belong to the volumetric methods, though), it is not fair to 
directly compare the performances among the methods. However, since those performances 
were obtained with the same ADNI cohort, it still deserves to compare their performances. 
Since previous work mostly focused on classification tasks of AD vs. NC and pMCI vs. 
sMCI, we summarize here only for these two tasks in Tables 7 and 8, respectively. First, in 
the AD vs. NC task, our method of JLLR+DeepESRNet achieved the highest accuracy and 
sensitivity. When comparing with Liu et al.’s results, the results are competitive. However, 
we would like to emphasize the improvements of 6.4% in sensitivity, which is clinically 
regarded more important than other metrics. In the meantime, for the task of pMCI vs. 
sMCI, Moradi et al.’s (2015) method that combined MRI features with age and cognitive 
measures for classification showed the highest accuracy and sensitivity. However, they 
considered a smaller-sized dataset than ours and their very low sensitivity raises doubts 
about an overfitting problem in their classifier, possibly due to a much smaller number of 
sMCI samples than the number of pMCI samples. Except for Moradi et al.’s method, our 
JLLR+DeepESRNet achieved the best accuracy, sensitivity, and specificity on the largest 
dataset, i.e., 167 pMCI subjects and 226 sMCI subjects.
6.5. Potential imaging biomarkers
It is worthy to understand and visualize ROIs selected in sparse regression models that 
provide useful information to extract target-representations, which are finally used by our 
deep model. Note that it doesn’t mean those selected ROIs used by deep learning directly. 
Fig. 5 shows the frequency distribution of the selected ROIs over 10-fold cross validation for 
three different classification tasks by our multiple JLLR. To identify brain regions that can 
be regarded as potential imaging biomarkers, we first identified the most selected features. 
We defined the most selected features based on their frequency, which should be higher than 
95,13 and then found the commonly selected ones across three tasks. The brain regions 
13The maximal frequency in our work is 100.
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corresponding to the commonly selected features are as follows: insula right, precentral 
gyrus right, lateral front-orbital gyrus right, frontal lobe WM left, cingulate region left, 
hippocampal formation right, superior parietal lobule left, middle temporal gyrus left, 
temporal lobe WM left, superior parietal lobule right, lateral front-orbital gyrus left, inferior 
temporal gyrus left, lateral occipitotemporal gyrus right, hippocampal formation left, medial 
occipitotemporal gyrus left, middle temporal gyrus right, and lateral occipitotemporal gyrus 
left.
7. Conclusions
In this paper, we proposed a novel method that combines two conceptually different models 
of sparse regression and deep CNN. Specifically, we proposed to build multiple sparse 
regression models with different values of a regularization control parameter. Next, we 
devised a CNN by taking the predictions from the multiple regression models as input for 
final clinical decision making. With an MRI dataset of 805 subjects from the ADNI cohort, 
our methods outperformed the competing methods in terms of statistical significance, 
rejecting the null hypothesis beyond the 95 percent confidence level. One of the limitations 
in our current work is related to the predefined number of regularization control parameter 
values. From a machine learning perspective, it is necessary to find the optimal number of 
regularization control parameter values from training data solely, which should be our future 
research issue. In the meantime, as end-to-end learning has verified its effectiveness, 
especially in deep learning (Long et al., 2015; Yang et al., 2016), we believe that there is a 
way to further improve the proposed method in that direction. That is, it is desirable to train 
parameters of both sparse regression models and a CNN jointly in a systematic manner.
As deep learning has achieved the state-of-the-art performance over different artificial 
intelligence applications, its use for performance enhancement is also one of the major steps 
in medical imaging. However, performance improvement in brain disease diagnosis is still 
minor. In order to foster the use of deep learning for imaging-based brain disease diagnosis, 
we suggest some directions. First, as witnessed in computer vision, where breakthrough 
improvements could be achieved by exploiting large amounts of training data, e.g., more 
than 1 million annotated images in ImageNet (Russakovsky et al., 2015), it would be one 
direction to build such big publicly available brain imaging datasets. These will help deep 
models to find more generalized features for brain disease diagnosis, thus allowing making a 
leap in performance. Second, it is necessary to develop algorithmic techniques to efficiently 
handle images acquired with different scanning protocols, by which there is no need to train 
scanning protocol-specific deep models. Third, it is desirable to develop a systematic 
framework for constructing an optimal network architecture, instead of empirical design. 
The performances are generally sensitive to the varying number of layers or units per layer 
(e.g., Tables 5 and 6). Last but not least, it is important to develop a method for identifying 
or interpreting deep learned features that mostly devoted to the predicted outputs, thus 
allowing for practical use in clinic.
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Appendix A. Performance by DBN+DNN
For a comparison purpose, we have also conducted an experiment with deep neural 
networks, whose parameter values were pretrained with Deep Belief Network (DBN) 
(Hinton and Salakhutdinov, 2006) by stacking multiple Restricted Boltzmann Machines 
(RBMs). Specifically, we exploited a Gaussian RBM for the bottom input-hidden RBM and 
binary RBMs for the upper hidden layers. For a Gaussian RBM, we fixed the standard 
deviations to 1 to reduce the number of parameters, thus avoiding overfitting and lessening 
training time (Nair and Hinton, 2008). In order for that, the training samples were first 
Gaussian normalized by subtracting with mean and then dividing with standard deviation. 
Regarding the DBN training, we used a contrastive-divergence algorithm (Hinton et al., 
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2006) with 100 epochs, a learning rate of 0.01, and a batch size of 10. The pretained DBN 
was then transformed into a deep neural network for which we attached a top output layer 
for classification. The performance is summarized in Table A1.
Table A1
Performance of (deep) neural networks, pretrained with Deep Belief Network (DBN), with 
93 regional volume features. The boldface denotes the best performance for each metric in 
each classification task.
# of 
hidden 
units Tasks Accuracy (%) Sensitivity (%) Specificity (%) BA (%) PPV (%) NPV (%) AUC
2-
layer 
DBN 
+ 
NN
50 AD vs. NC 85.41 ± 4.80 85.15 86.58 85.87 82.75 87.57 0.9197
MCI vs. NC 65.46 ± 5.42 69.66 56.17 62.91 80.73 38.99 0.6963
pMCI vs. sMCI 62.85 ± 7.80 57.72 66.81 62.26 53.31 69.90 0.6786
100 AD vs. NC 83.97 ± 4.22 85.09 83.87 84.48 78.51 88.48 0.9174
MCI vs. NC 66.43 ± 6.33 70.34 56.95 63.64 81.24 40.69 0.6966
pMCI vs. sMCI 63.33 ± 7.42 57.73 67.03 62.38 51.47 72.08 0.6707
3-
layer 
DBN 
+ 
NN
50-30 AD vs. NC 85.91 ± 5.32 85.55 86.91 86.23 83.30 88.04 0.9082
MCI vs. NC 65.78 ± 6.53 69.44 56.97 63.21 82.24 37.13 0.6980
pMCI vs. sMCI 59.48 ± 7.75 52.53 63.64 58.09 45.26 69.84 0.6194
100-30 AD vs. NC 84.68 ± 6.08 86.59 84.25 85.42 78.51 89.80 0.9102
MCI vs. NC 64.32 ± 4.76 68.86 53.89 61.37 79.97 37.15 0.6848
pMCI vs. sMCI 65.35 ± 7.60 60.11 69.21 64.66 56.25 72.13 0.6651
4-
layer 
DBN 
+ 
NN
50-50-30 AD vs. NC 85.40 ± 6.32 85.68 85.81 85.84 81.17 88.87 0.9062
MCI vs. NC 62.71 ± 4.79 68.55 51.05 59.80 77.46 37.09 0.6438
pMCI vs. sMCI 59.01 ± 5.42 52.36 61.68 57.02 34.49 77.00 0.6146
100-50-30 AD vs. NC 82.77 ± 5.77 82.89 83.48 83.19 78.01 86.72 0.8867
MCI vs. NC 65.93 ± 3.05 69.16 57.36 63.26 84.02 34.31 0.6667
pMCI vs. sMCI 57.24 ± 7.27 50.98 61.42 56.20 40.74 69.41 0.5822
Appendix B. List of 93 ROIs
See Table B1.
Table B1
A list of 93 ROIs considered in this work.
medial front-orbital gyrus right middle frontal gyrus right lateral ventricle left
insula right precentral gyrus right lateral front-orbital gyrus right
cingulate region right lateral ventricle right medial frontal gyrus left
superior frontal gyrus right globus palladus right globus palladus left
putamen left inferior frontal gyrus left putamen right
frontal lobe WM right parahippocampal gyrus left angular gyrus right
temporal pole right subthalamic nucleus right nucleus accumbens right
Suk et al. Page 22
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
uncus right cingulate region left fornix left
frontal lobe WM left precuneus right subthalamic nucleus left
posterior limb of internal capsule inc. 
cerebral peduncle left
posterior limb of internal capsule inc. 
cerebral peduncle right
hippocampal formation right
inferior occipital gyrus left superior occipital gyrus right caudate nucleus left
supramarginal gyrus left anterior limb of internal capsule left occipital lobe WM right
middle frontal gyrus left superior parietal lobule left caudate nucleus right
cuneus left precuneus left parietal lobe WM left
temporal lobe WM right supramarginal gyrus right superior temporal gyrus left
uncus left middle occipital gyrus right middle temporal gyrus left
lingual gyrus left superior frontal gyrus left nucleus accumbens left
occipital lobe WM left postcentral gyrus left inferior frontal gyrus right
precentral gyrus left temporal lobe WM left medial front-orbital gyrus left
perirhinal cortex right superior parietal lobule right lateral front-orbital gyrus left
perirhinal cortex left inferior temporal gyrus left temporal pole left
entorhinal cortex left inferior occipital gyrus right superior occipital gyrus left
lateral occipitotemporal gyrus right entorhinal cortex right hippocampal formation left
thalamus left parietal lobe WM right insula left
postcentral gyrus right lingual gyrus right medial frontal gyrus right
amygdala left medial occipitotemporal gyrus left parahippocampal gyrus right
anterior limb of internal capsule right middle temporal gyrus right occipital pole right
corpus callosum amygdala right inferior temporal gyrus right
superior temporal gyrus right middle occipital gyrus left angular gyrus left
medial occipitotemporal gyrus right cuneus right lateral occipitotemporal gyrus left
thalamus right occipital pole left fornix right
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Fig. 1. 
Multiple sparse regression models with different values of a sparse control parameter, where 
λ1 < ··· < λm < ··· < λM. The prediction function f (·) is defined by Eq. (6).
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Fig. 2. 
Proposed convolutional neural network of modeling deep ensemble sparse regressions for 
brain disorder diagnosis. (I: input, C: convolution, M: max-pooling, F: fully-connect, O: 
output). The online color version provides a clearer view. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of this 
article).
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Fig. 3. 
Samples of target-level representations, which were Gaussian normalized by first subtracting 
with means and then dividing with standard deviations, and the correlation matrix that 
represents relations among four sparse regression models.
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Fig. 4. 
Performance comparison between MOLR+DeepESRNet and JLLR+DeepESRNet.
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Fig. 5. 
Distribution of the selected ROIs by JLLR for different classification tasks. The color 
denotes the frequency of being selected in 10-fold cross-validation. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of this 
article).
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Table 1
Demographic and clinical information of the subjects. (pMCI: progressive MCI, sMCI: stable MCI, SD: 
Standard Deviation).
AD pMCI sMCI NC
Number of subjects 186 167 226 226
 Female/male 87/99 65/102 75/151 108/118
Age (Mean ± SD) 75.37 ± 7.55 74.89 ± 6.83 75.00 ± 7.63 75.96 ± 5.04
Education years (Mean ± SD) 14.70 ± 3.13 15.69 ± 2.87 15.62 ± 3.18 16.03 ± 2.88
MMSE (Mean ± SD) 23.28 ± 2.02 26.59 ± 1.71 27.28 ± 1.77 29.11 ± 1.00
ADAS-Cog (Mean ± SD) 18.44 ± 6.71 13.30 ± 4.05 10.33 ± 4.31 6.21 ± 2.93
CDR (Mean ± SD) 0.75 ± 0.25 0.50 ± 0.00 0.50 ± 0.03 0.00 ± 0.00
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Table 4
Statistical significance test.
Task
MOLR + DeepESRNet JLLR + DeepESRNet
MOLR MOLR + SVM JLLR JLLR + SVM
AD vs. NC 0.0078 0.0312 0.0020 0.0059
MCI vs. NC 0.0020 0.0039 0.0234 0.0078
pMCI vs. sMCI 0.0020 0.0039 0.0117 0.0020
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Suk et al. Page 33
Ta
bl
e 
5
Pe
rfo
rm
an
ce
 o
f (
de
ep
) n
eu
ral
 ne
tw
o
rk
s, 
pr
et
ra
in
ed
 w
ith
 S
ta
ck
ed
 A
ut
o-
En
co
de
r (
SA
E)
, w
ith
 93
 re
gi
on
al
 fe
at
ur
es
. T
he
 b
ol
df
ac
e 
de
no
te
s t
he
 b
es
t 
pe
rfo
rm
an
ce
 fo
r e
ac
h 
m
et
ric
 in
 e
ac
h 
cl
as
sif
ic
at
io
n 
ta
sk
.
# 
of
 h
id
de
n 
un
its
Ta
sk
s
A
cc
ur
ac
y 
(%
)
Se
ns
iti
v
ity
 (%
)
Sp
ec
ifi
ci
ty
 (%
)
BA
 (%
)
PP
V
 (%
)
N
PV
 (%
)
AU
C
2-
la
ye
r S
A
E 
+ 
N
N
50
A
D
 v
s. 
N
C
86
.1
6 
± 
4.
28
87
.0
4
86
.5
9
86
.8
2
82
.2
2
89
.4
1
0.
93
21
M
CI
 v
s. 
N
C
67
.3
9 
± 
6.
84
73
.5
0
56
.3
6
64
.9
3
76
.1
1
52
.3
1
0.
71
41
pM
CI
 v
s. 
sM
CI
64
.3
9 
± 
8.
64
57
.8
1
69
.6
7
63
.7
4
57
.5
0
69
.4
9
0.
69
54
10
0
A
D
 v
s. 
N
C
86
.6
4 
± 
4.
92
87
.1
5
87
.1
2
87
.1
4
83
.3
0
89
.4
1
0.
93
06
M
CI
 v
s. 
N
C
69
.1
9 
±
 8
.1
9
74
.4
6
58
.9
6
66
.7
1
78
.4
2
53
.1
6
0.
72
33
pM
CI
 v
s. 
sM
CI
66
.3
9 
± 
7.
48
60
.9
7
70
.4
6
65
.7
1
57
.3
9
73
.0
0
0.
71
79
3-
la
ye
r S
A
E 
+ 
N
N
50
-3
0
A
D
 v
s. 
N
C
86
.8
7 
± 
5.
14
86
.2
4
88
.1
9
87
.2
2
84
.9
1
88
.5
0
0.
92
49
M
CI
 v
s. 
N
C
69
.0
2 
± 
6.
00
74
.6
7
58
.9
7
66
.8
2
77
.4
0
54
.4
9
0.
73
87
pM
CI
 v
s. 
sM
CI
69
.1
8 
±
 6
.6
5
64
.5
2
72
.7
4
68
.6
3
61
.0
7
75
.1
4
0.
74
01
10
0-
30
A
D
 v
s. 
N
C
87
.8
5 
±
 5
.3
3
88
.9
9
88
.1
2
88
.5
6
84
.3
6
90
.7
3
0.
92
72
M
CI
 v
s. 
N
C
67
.5
8 
± 
8.
65
72
.9
7
57
.0
2
65
.0
0
77
.6
5
50
.1
4
0.
71
03
pM
CI
 v
s. 
sM
CI
68
.9
3 
± 
7.
17
64
.3
0
72
.3
7
68
.3
3
60
.9
9
74
.8
0
0.
73
47
4-
la
ye
r S
A
E 
+ 
N
N
50
-5
0-
30
A
D
 v
s. 
N
C
85
.4
3 
± 
4.
99
85
.3
7
86
.6
1
85
.9
9
82
.7
5
87
.6
1
0.
92
01
M
CI
 v
s. 
N
C
67
.4
0 
± 
6.
87
74
.1
0
55
.6
0
64
.8
5
74
.8
3
54
.4
9
0.
71
94
pM
CI
 v
s. 
sM
CI
66
.6
5 
± 
8.
21
60
.3
3
72
.2
7
66
.3
0
62
.1
7
69
.9
2
0.
70
59
10
0-
50
-3
0
A
D
 v
s. 
N
C
87
.1
1 
± 
5.
78
86
.9
2
88
.2
5
87
.5
8
84
.9
1
88
.9
1
0.
92
12
M
CI
 v
s. 
N
C
68
.6
9 
± 
7.
51
74
.7
2
58
.2
9
66
.5
1
76
.6
2
54
.9
4
0.
71
82
pM
CI
 v
s. 
sM
CI
67
.3
7 
± 
7.
09
62
.0
4
71
.8
5
66
.9
4
62
.2
1
71
.1
9
0.
72
24
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Suk et al. Page 34
Ta
bl
e 
6
Pe
rfo
rm
an
ce
 o
f (
de
ep
) n
eu
ral
 ne
tw
o
rk
s, 
pr
et
ra
in
ed
 w
ith
 S
ta
ck
ed
 A
ut
o-
En
co
de
r (
SA
E)
, ta
kin
g v
ec
to
riz
ed
 ta
rg
et
-le
v
el
 re
pr
es
en
ta
tio
ns
 a
s i
np
ut
. T
he
 
bo
ld
fa
ce
 d
en
ot
es
 th
e 
be
st 
pe
rfo
rm
an
ce
 fo
r e
ac
h 
m
et
ric
 in
 e
ac
h 
cl
as
sif
ic
at
io
n 
ta
sk
.
# 
of
 h
id
de
n 
un
its
Ta
sk
s
A
cc
ur
ac
y 
(%
)
Se
ns
iti
v
ity
 (%
)
Sp
ec
ifi
ci
ty
 (%
)
BA
 (%
)
PP
V
 (%
)
N
PV
 (%
)
AU
C
2-
la
ye
r S
A
E 
+ 
N
N
50
A
D
 v
s. 
N
C
86
.8
6 
±
 4
.9
7
81
.7
0
91
.1
1
86
.4
0
88
.8
8
86
.2
9
0.
93
00
M
CI
 v
s. 
N
C
68
.3
8 
± 
7.
60
78
.1
8
51
.3
8
64
.7
8
73
.6
3
58
.2
3
0.
72
33
pM
CI
 v
s. 
sM
CI
66
.9
3 
± 
7.
01
55
.6
6
75
.2
2
65
.4
4
62
.6
9
70
.0
6
0.
71
83
10
0
A
D
 v
s. 
N
C
86
.3
8 
± 
3.
39
82
.1
9
89
.8
0
86
.0
0
87
.6
7
86
.4
8
0.
92
19
M
CI
 v
s. 
N
C
68
.3
8 
± 
6.
90
78
.4
3
50
.9
5
64
.6
9
73
.5
0
58
.2
7
0.
72
12
pM
CI
 v
s. 
sM
CI
67
.9
4 
±
 8
.6
8
59
.1
9
74
.3
5
66
.7
7
63
.2
8
71
.5
5
0.
72
32
3-
la
ye
r S
A
E 
+ 
N
N
50
–3
0
A
D
 v
s. 
N
C
86
.3
6 
± 
5.
01
81
.1
4
90
.6
5
85
.9
0
88
.4
7
85
.9
9
0.
92
74
M
CI
 v
s. 
N
C
69
.1
8 
±
 6
.2
4
77
.4
1
54
.9
0
66
.1
6
74
.9
4
59
.1
4
0.
72
36
pM
CI
 v
s. 
sM
CI
67
.7
0 
± 
7.
00
57
.4
3
75
.2
4
66
.3
3
63
.5
6
70
.7
2
0.
74
53
10
0–
30
A
D
 v
s. 
N
C
86
.7
3 
± 
5.
37
81
.1
4
90
.6
7
85
.9
1
88
.2
5
85
.9
3
0.
93
41
M
CI
 v
s. 
N
C
68
.2
2 
± 
7.
45
75
.3
7
55
.8
3
65
.6
0
74
.8
6
56
.9
9
0.
73
03
pM
CI
 v
s. 
sM
CI
67
.4
4 
± 
7.
99
58
.0
1
74
.3
3
66
.1
7
62
.8
7
70
.8
4
0.
72
77
4-
la
ye
r S
A
E 
+ 
N
N
50
–5
0–
30
A
D
 v
s. 
N
C
86
.6
0 
± 
5.
01
81
.6
7
90
.6
5
86
.1
6
88
.6
3
86
.2
4
0.
91
55
M
CI
 v
s. 
N
C
68
.6
9 
± 
6.
19
76
.1
5
55
.7
7
65
.9
6
75
.1
2
57
.9
6
0.
72
68
pM
CI
 v
s. 
sM
CI
66
.9
3 
± 
7.
76
58
.0
1
73
.4
8
65
.7
5
62
.0
5
70
.5
5
0.
73
26
10
0–
50
–3
0
A
D
 v
s. 
N
C
86
.3
6 
± 
5.
01
81
.6
7
90
.2
2
85
.9
4
88
.0
5
86
.1
8
0.
90
26
M
CI
 v
s. 
N
C
67
.3
9 
± 
6.
01
74
.8
5
54
.4
7
64
.6
6
74
.1
2
56
.0
7
0.
72
31
pM
CI
 v
s. 
sM
CI
67
.7
0 
± 
8.
20
59
.8
2
73
.4
4
66
.6
3
63
.2
4
71
.4
9
0.
73
74
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Suk et al. Page 35
Ta
bl
e 
7
Co
m
pa
ris
on
 w
ith
 th
e 
pr
ev
io
us
 st
ud
ie
s o
f A
D
 v
s. 
N
C 
cl
as
sif
ic
at
io
n 
on
 A
D
N
I d
at
as
et
. T
he
 b
ol
df
ac
e 
de
no
te
s t
he
 b
es
t p
er
fo
rm
an
ce
 fo
r e
ac
h 
m
et
ric
. (G
M
: 
G
ra
y 
M
at
te
r; 
SV
M
: S
up
po
rt 
Ve
ct
or
 M
ac
hi
ne
; C
T:
 C
or
tic
al
 T
hi
ck
ne
ss
; P
CA
: P
rin
ci
pa
l C
om
po
ne
nt
 A
na
ly
sis
; L
DA
: L
in
ea
r D
isc
rim
in
an
t A
na
ly
sis
; R
O
I: 
R
eg
io
n 
O
f I
nt
er
es
t; 
QD
A
: Q
ua
dra
tic
 D
isc
rim
ina
nt 
An
aly
sis
; R
LR
: R
eg
ul
ar
iz
ed
 L
in
ea
r R
eg
re
ss
io
n;
 S
A
E:
 S
ta
ck
ed
 A
ut
o-
En
co
de
r).
M
et
ho
d
Fe
a
tu
re
 T
yp
e
C
la
ss
ifi
er
Su
bje
cts
 (A
D/
NC
)
A
cc
ur
ac
y 
(%
)
Se
ns
iti
v
ity
 (%
)
Sp
ec
ifi
ci
ty
 (%
)
Zh
an
g 
an
d 
Sh
en
 (2
01
2)
G
M
 v
o
lu
m
es
SV
M
45
/5
0
84
.8
0
–
–
Ch
o 
et
 a
l. 
(20
12
)
CT
PC
A
+L
DA
12
8/
16
0
–
82
.0
0
93
.0
0
Co
up
é 
et
 a
l. 
(20
12
)
H
P/
EC
 v
o
lu
m
es
QD
A
60
/6
0
90
.0
0
88
.0
0
92
.0
0
Li
u 
et
 a
l. 
(20
12
)
G
M
 v
o
x
el
s
En
se
m
bl
e 
SR
C
19
8/
22
9
90
.8
0
86
.3
2
94
.7
6
Ca
sa
no
v
a 
et
 a
l. 
(20
13
)
G
M
 v
o
x
el
s
R
LR
17
1/
18
8
87
.1
0
84
.3
0
88
.9
0
Es
ki
ld
se
n 
et
 a
l. 
(20
13
)
RO
I C
T
LD
A
19
4/
22
6
84
.5
0
79
.4
0
88
.9
0
Sc
hm
itt
er
 e
t a
l. 
(20
15
)
10
 V
o
lu
m
es
SV
M
22
1/
27
6
–
86
.0
0
91
.0
0
Su
k 
et
 a
l. 
(20
15
a)
G
M
 v
o
lu
m
es
+S
A
E
SV
M
51
/5
2
88
.2
0
–
–
Pr
op
os
ed
G
M
 v
o
lu
m
es
JL
LR
+D
ee
pE
SM
18
6/
22
6
91
.0
2
92
.7
2
89
.9
4
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Suk et al. Page 36
Ta
bl
e 
8
Co
m
pa
ris
on
 w
ith
 th
e 
pr
ev
io
us
 st
ud
ie
s o
f p
M
CI
 v
s. 
sM
CI
 c
la
ss
ifi
ca
tio
n 
on
 A
D
N
I d
at
as
et
. T
he
 b
ol
df
ac
e 
de
no
te
s t
he
 b
es
t p
er
fo
rm
an
ce
 fo
r e
ac
h 
m
et
ric
. 
(G
M
: G
ray
 M
att
er;
 SV
M
: S
up
po
rt 
Ve
ct
or
 M
ac
hi
ne
; C
T:
 C
or
tic
al
 T
hi
ck
ne
ss
; P
CA
: P
rin
ci
pa
l C
om
po
ne
nt
 A
na
ly
sis
; L
DA
: L
in
ea
r D
isc
rim
in
an
t A
na
ly
sis
; 
RO
I: 
Re
gi
on
 O
f I
nt
er
es
t; 
RL
R:
 R
eg
ul
ar
iz
ed
 L
in
ea
r R
eg
re
ss
io
n;
 L
D
S:
 L
ow
 D
en
sit
y 
Se
pa
ra
tio
n;
 S
A
E:
 S
ta
ck
ed
 A
ut
o-
En
co
de
r).
M
et
ho
d
Fe
a
tu
re
 T
yp
e
C
la
ss
ifi
er
Su
bje
cts
 (p
M
CI
/sM
CI
)
A
cc
ur
ac
y 
(%
)
Se
ns
iti
v
ity
 (%
)
Sp
ec
ifi
ci
ty
 (%
)
Zh
an
g 
an
d 
Sh
en
 (2
01
2)
G
M
 v
o
lu
m
es
SV
M
43
/4
8
62
.0
0
56
.6
0
60
.2
0
Ch
o 
et
 a
l. 
(20
12
)
CT
PC
A
+L
DA
72
/1
31
–
63
.0
0
76
.0
0
Es
ki
ld
se
n 
et
 a
l. 
(20
13
)
RO
I C
T
LD
A
61
/1
34
66
.7
0
59
.0
0
70
.2
0
Ca
sa
no
v
a 
et
 a
l. 
(20
13
)
G
M
 v
o
x
el
s
R
LR
15
3/
18
2
61
.5
0
45
.8
0
75
.5
0
M
or
ad
i e
t a
l. 
(20
15
)
G
M
 v
o
x
el
s+
ag
e 
+c
lin
ic
al
 sc
or
es
LD
S
16
4/
10
0
76
.6
1
88
.8
5
51
.5
9
Sc
hm
itt
er
 e
t a
l. 
(20
15
)
10
 v
o
lu
m
es
SV
M
14
7/
25
4
–
67
.0
0
71
.0
0
Su
k 
et
 a
l. 
(20
15
a)
G
M
 v
o
lu
m
es
+S
A
E
SV
M
43
/5
6
69
.3
0
–
–
Pr
op
os
ed
G
M
 v
o
lu
m
es
JL
LR
+D
ee
pE
SM
16
7/
22
6
74
.8
2
70
.9
3
78
.8
2
Med Image Anal. Author manuscript; available in PMC 2018 February 12.
